Efficacy News and Research

RSS
Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

On-going phase II trial of octagam in AD to be discussed at ICAD 2010

On-going phase II trial of octagam in AD to be discussed at ICAD 2010

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

Homeopathy – Is it a safer and effective alternative?

Homeopathy – Is it a safer and effective alternative?

OECs may hold promise for pediatric cerebral palsy treatment

OECs may hold promise for pediatric cerebral palsy treatment

Generex Biotechnology announces plan to obtain cost reimbursement coverage for Generex Oal-lyn

Generex Biotechnology announces plan to obtain cost reimbursement coverage for Generex Oal-lyn

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds 19,490-patient study

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

NanoImaging Services receives grant to develop methods for characterization of nanoparticle morphology

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Smith & Nephew highlights advanced wound care product portfolio at 2010 SAWC/WHS meeting

Smith & Nephew highlights advanced wound care product portfolio at 2010 SAWC/WHS meeting

Potential drug to annul ADAM-17 protein activity needed

Potential drug to annul ADAM-17 protein activity needed

Encouraging early data from Bellicum Pharmaceuticals' Phase I/II study of BPX-101 for mCRPC

Encouraging early data from Bellicum Pharmaceuticals' Phase I/II study of BPX-101 for mCRPC

Surgery still the only measure to cure RCC

Surgery still the only measure to cure RCC

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Organogenesis to showcase study results of Apligraf product at SAWC / WHS 2010

Organogenesis to showcase study results of Apligraf product at SAWC / WHS 2010

Results from Phase 2 study of BOTOX in IOAB patients presented at Anniversary EAU Congress

Results from Phase 2 study of BOTOX in IOAB patients presented at Anniversary EAU Congress

Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010

Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.